Sensorion SA (ALSEN) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.332x

Based on the latest financial reports, Sensorion SA (ALSEN) has a cash flow conversion efficiency ratio of -0.332x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-18.94 Million ≈ $-22.14 Million USD) by net assets (€56.98 Million ≈ $66.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Sensorion SA fund operations to measure how many days the company can operate on defensive assets alone.

Sensorion SA - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Sensorion SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sensorion SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sensorion SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Al-Bad Massuot Yitzhak Ltd TA:ALBA	0.065x
Meridian Holdings Inc NASDAQ:MRDN	0.102x
Peninsula Energy Ltd AU:PEN	-0.085x
Zumtobel Group AG VI:ZAG	0.079x
Clavister Holding AB (publ.) ST:CLAV	-0.204x
EDAP TMS SA NASDAQ:EDAP	-0.294x
NH SPAC 2 KQ:206640	0.043x
Uniplus Electronics Co Ltd TWO:5381	0.035x

Annual Cash Flow Conversion Efficiency for Sensorion SA (2012–2024)

The table below shows the annual cash flow conversion efficiency of Sensorion SA from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Sensorion SA stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€72.14 Million ≈ $84.34 Million	€-21.33 Million ≈ $-24.94 Million	-0.296x	+53.30%
2023-12-31	€33.28 Million ≈ $38.90 Million	€-21.07 Million ≈ $-24.63 Million	-0.633x	+35.30%
2022-12-31	€21.87 Million ≈ $25.57 Million	€-21.41 Million ≈ $-25.02 Million	-0.979x	-299.56%
2021-12-31	€43.98 Million ≈ $51.42 Million	€-10.77 Million ≈ $-12.59 Million	-0.245x	-168.93%
2020-12-31	€58.35 Million ≈ $68.21 Million	€-5.31 Million ≈ $-6.21 Million	-0.091x	+91.51%
2019-12-31	€13.21 Million ≈ $15.45 Million	€-14.17 Million ≈ $-16.56 Million	-1.072x	+69.27%
2018-12-31	€3.51 Million ≈ $4.10 Million	€-12.25 Million ≈ $-14.32 Million	-3.489x	-228.29%
2017-12-31	€7.32 Million ≈ $8.56 Million	€-7.78 Million ≈ $-9.10 Million	-1.063x	-26.94%
2016-12-31	€8.59 Million ≈ $10.04 Million	€-7.19 Million ≈ $-8.41 Million	-0.837x	-112.45%
2015-12-31	€12.82 Million ≈ $14.99 Million	€-5.05 Million ≈ $-5.91 Million	-0.394x	-105.53%
2014-12-31	€-323.20K ≈ $-377.85K	€-2.30 Million ≈ $-2.69 Million	7.130x	+504.41%
2013-12-31	€-1.20 Million ≈ $-1.40 Million	€-1.42 Million ≈ $-1.66 Million	1.180x	+103.73%
2012-12-31	€26.11K ≈ $30.53K	€-826.03K ≈ $-965.71K	-31.636x	--

About Sensorion SA

PA:ALSEN France Biotechnology

Market Cap

$154.93 Million

€132.52 Million EUR

Market Cap Rank

#17611 Global

#261 in France

Share Price

€0.26

Change (1 day)

+11.47%

52-Week Range

€0.23 - €0.70

All Time High

€12.53